• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺苷受体建模:A2A 晶体结构告诉了我们什么?

Adenosine receptor modeling: what does the A2A crystal structure tell us?

机构信息

School of Pharmacy, Medicinal Chemistry Unit, University of Camerino, 62032 Camerino (MC), Italy.

出版信息

Curr Top Med Chem. 2010;10(10):993-1018. doi: 10.2174/156802610791293145.

DOI:10.2174/156802610791293145
PMID:20370656
Abstract

For a long time, there have been no experimentally determined structural data for any adenosine receptor (AR) and the only approach available for making structure/function correlations about these proteins has been homology modeling. While the early attempts to model these receptors followed the crystallization of bacteriorhodopsin, the cryo-microscopy studies of bovine and frog rhodopsin, and the modeling of a Calpha-template for the TM helices in the rhodopsin family of GPCRs, the crystallization of bovine rhodopsin by Palczewski was of extreme importance as it first provided the crystal structure of an eukaryotic GPCR to be used as template for more realistic homology models. Since then, rhodopsin-based modeling became the routine approach to develop AR structural models that proved to be useful for interpretation of site-directed mutagenesis data and for molecular docking studies. The recently reported crystal structures of the adrenergic beta1 and beta2 receptors only partially confirmed the structural features showed by bovine rhodopsin, raising a question about which template would have been better for further modeling of ARs. Such question remained actually not-answered, due to the publication in late 2008 of the crystal structure of human adenosine A(2A) receptor (AA(2A)R). Since its publication, this structure has been used for ligands docking analysis and has provided a high similarity template for homology modeling of the other AR subtypes. Still, the AA(2A)R crystal structure allows to verify the hypotheses that were made on the basis of the previously reported homology modeling and molecular docking.

摘要

长期以来,一直没有任何腺苷受体 (AR) 的实验确定的结构数据,并且对这些蛋白质进行结构/功能相关性研究的唯一方法是同源建模。虽然早期对这些受体进行建模的尝试是基于细菌视紫红质的结晶、牛和蛙视紫红质的冷冻电子显微镜研究以及视紫红质家族 GPCR 中 TM 螺旋的 Calpha 模板建模,但 Palczewski 对牛视紫红质的结晶是非常重要的,因为它首次提供了真核 GPCR 的晶体结构,可作为更现实的同源模型的模板。从那时起,基于视紫红质的建模成为开发 AR 结构模型的常规方法,这些模型被证明对于解释定点突变数据和分子对接研究非常有用。最近报道的肾上腺素能β1 和β2 受体的晶体结构仅部分证实了牛视紫红质所显示的结构特征,这引发了一个问题,即哪个模板更适合进一步建模 AR。由于 2008 年底人腺苷 A(2A)受体 (AA(2A)R) 的晶体结构的发表,这个问题实际上仍然没有得到回答。自其发表以来,该结构已用于配体对接分析,并为其他 AR 亚型的同源建模提供了高度相似的模板。尽管如此,AA(2A)R 晶体结构允许验证基于先前报道的同源建模和分子对接所提出的假设。

相似文献

1
Adenosine receptor modeling: what does the A2A crystal structure tell us?腺苷受体建模:A2A 晶体结构告诉了我们什么?
Curr Top Med Chem. 2010;10(10):993-1018. doi: 10.2174/156802610791293145.
2
Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.A1和A2A腺苷受体的分子模拟:通过对接研究比较基于视紫红质和β2肾上腺素能的同源模型
J Comput Chem. 2009 Jan 15;30(1):14-32. doi: 10.1002/jcc.21001.
3
X-ray structure breakthroughs in the GPCR transmembrane region.G蛋白偶联受体跨膜区域的X射线结构突破。
Biochem Pharmacol. 2009 Jul 1;78(1):11-20. doi: 10.1016/j.bcp.2009.02.012. Epub 2009 Feb 27.
4
Evaluation of homology modeling of G-protein-coupled receptors in light of the A(2A) adenosine receptor crystallographic structure.基于A(2A)腺苷受体晶体结构对G蛋白偶联受体同源建模的评估。
J Med Chem. 2009 May 28;52(10):3284-92. doi: 10.1021/jm801533x.
5
Homology modelling of the human adenosine A2B receptor based on X-ray structures of bovine rhodopsin, the beta2-adrenergic receptor and the human adenosine A2A receptor.基于牛视紫红质、β2-肾上腺素能受体和人腺苷 A2A 受体的 X 射线结构对人腺苷 A2B 受体进行同源建模。
J Comput Aided Mol Des. 2009 Nov;23(11):807-28. doi: 10.1007/s10822-009-9299-7.
6
Discovery of Novel Adenosine Receptor Antagonists through a Combined Structure- and Ligand-Based Approach Followed by Molecular Dynamics Investigation of Ligand Binding Mode.通过基于结构和配体的联合方法发现新型腺苷受体拮抗剂,并通过分子动力学研究配体结合模式。
J Chem Inf Model. 2018 Apr 23;58(4):794-815. doi: 10.1021/acs.jcim.7b00455. Epub 2018 Mar 19.
7
Beyond rhodopsin: G protein-coupled receptor structure and modeling incorporating the beta2-adrenergic and adenosine A(2A) crystal structures.超越视紫红质:结合β2肾上腺素能受体和腺苷A(2A)晶体结构的G蛋白偶联受体结构与建模
Methods Mol Biol. 2011;672:359-86. doi: 10.1007/978-1-60761-839-3_15.
8
Human A3 adenosine receptor as versatile G protein-coupled receptor example to validate the receptor homology modeling technology.人 A3 腺苷受体作为多功能 G 蛋白偶联受体的范例,验证了受体同源建模技术。
Curr Pharm Des. 2009;15(35):4069-84. doi: 10.2174/138161209789824777.
9
Structural Mapping of Adenosine Receptor Mutations: Ligand Binding and Signaling Mechanisms.腺苷受体突变的结构映射:配体结合和信号转导机制。
Trends Pharmacol Sci. 2018 Jan;39(1):75-89. doi: 10.1016/j.tips.2017.11.001. Epub 2017 Dec 5.
10
Limits of ligand selectivity from docking to models: in silico screening for A(1) adenosine receptor antagonists.从对接至模型看配体的选择性限制:A(1) 腺苷受体拮抗剂的计算机筛选。
PLoS One. 2012;7(11):e49910. doi: 10.1371/journal.pone.0049910. Epub 2012 Nov 21.

引用本文的文献

1
Structure-Activity Relationship Analysis of 2-Aryl-8-alkynyl Adenine and Nucleoside Scaffolds as A Adenosine Receptor Ligands.2-芳基-8-炔基腺嘌呤和核苷支架作为腺苷受体配体的构效关系分析
ACS Med Chem Lett. 2025 Apr 2;16(5):880-886. doi: 10.1021/acsmedchemlett.5c00138. eCollection 2025 May 8.
2
Bell-Evans model and steered molecular dynamics in uncovering the dissociation kinetics of ligands targeting G-protein-coupled receptors.贝尔-埃文斯模型和导向分子动力学在揭示靶向 G 蛋白偶联受体的配体解离动力学中的应用。
Sci Rep. 2022 Sep 24;12(1):15972. doi: 10.1038/s41598-022-20065-2.
3
Non-Nucleoside Agonists of the Adenosine Receptors: An Overview.
腺苷受体的非核苷类激动剂:综述
Pharmaceuticals (Basel). 2019 Oct 8;12(4):150. doi: 10.3390/ph12040150.
4
Simulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A2B adenosine receptor.A2B 腺苷受体上核苷类和非核苷类激动剂结合模式的模拟与比较分析
In Silico Pharmacol. 2013 Dec 20;1:24. doi: 10.1186/2193-9616-1-24. eCollection 2013.
5
Synthesis and anti-renal fibrosis activity of conformationally locked truncated 2-hexynyl-N(6)-substituted-(N)-methanocarba-nucleosides as A3 adenosine receptor antagonists and partial agonists.构象锁定的截断 2-己炔基-N(6)-取代-(N)-甲羰卡巴核苷作为 A3 腺苷受体拮抗剂和部分激动剂的合成及抗肾纤维化活性。
J Med Chem. 2014 Feb 27;57(4):1344-54. doi: 10.1021/jm4015313. Epub 2014 Feb 5.
6
Synthesis, biological activity and molecular modelling studies of tricyclic alkylimidazo-, pyrimido- and diazepinopurinediones.三环烷基咪唑并、嘧啶并和二氮杂苯并嘌呤二酮的合成、生物活性及分子建模研究。
Purinergic Signal. 2013 Sep;9(3):395-414. doi: 10.1007/s11302-013-9358-3. Epub 2013 Apr 2.
7
G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions.G 蛋白偶联腺苷(P1)和 P2Y 受体:配体设计和受体相互作用。
Purinergic Signal. 2012 Sep;8(3):419-36. doi: 10.1007/s11302-012-9294-7. Epub 2012 Feb 29.
8
Identification of novel adenosine A(2A) receptor antagonists by virtual screening.通过虚拟筛选鉴定新型腺苷 A(2A)受体拮抗剂。
J Med Chem. 2012 Mar 8;55(5):1904-9. doi: 10.1021/jm201455y. Epub 2012 Feb 23.
9
Discovery of 1,2,4-triazine derivatives as adenosine A(2A) antagonists using structure based drug design.基于结构的药物设计发现 1,2,4-三嗪衍生物作为腺苷 A(2A)拮抗剂。
J Med Chem. 2012 Mar 8;55(5):1898-903. doi: 10.1021/jm201376w. Epub 2012 Jan 27.
10
Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine.腺苷 A(2A)受体与 ZM241385、黄嘌呤衍生物 XAC 和咖啡因复合物的结构。
Structure. 2011 Sep 7;19(9):1283-93. doi: 10.1016/j.str.2011.06.014.